Medical and health care applications of nanotechnology have increasingly attracted research and innovation attention. Nano-biomedical science (NBMS) is a term we use to define this emerging domain. As China is one of the leading countries in nanotechnology, but lacks a long history as a biosciences leader, this paper explores the competitive positioning of China in the development of NBMS. Specifically, this paper profiles the research patterns of Chinese NBMS in comparison with the four other largest countries in NBMS, using bibliometric techniques. The results indicate that China is a leader in NBMS, leveraging its strengths in chemistry and physics in the broader nanotechnology domain. However, China’s relative weakness in traditional biomedical disciplines, and its lack of presence in highly influential global journals, could prove to be limiting factors.
Author(s): Ruimin Pei, Jan Youtie & Alan L. Porter
Organization(s): Beijing Institute of Technology, Georgia Institute of Technology
Source: Technology Analysis & Strategic Management, Volume 24, Issue 1